Edition:
United States

La Jolla Pharmaceutical Co (LJPC.OQ)

LJPC.OQ on NASDAQ Stock Exchange Capital Market

24.29USD
14 Dec 2017
Change (% chg)

$-2.30 (-8.65%)
Prev Close
$26.59
Open
$26.90
Day's High
$26.90
Day's Low
$23.90
Volume
165,367
Avg. Vol
108,254
52-wk High
$39.26
52-wk Low
$16.43

Latest Key Developments (Source: Significant Developments)

La Jolla Pharma files for mixed shelf of up to $150 mln ‍​
Friday, 27 Oct 2017 05:42pm EDT 

Oct 27 (Reuters) - La Jolla Pharmaceutical Co :Files for mixed shelf of up to $150 million - SEC filing‍​.  Full Article

La Jolla reports Q3 loss $1.19/shr
Thursday, 26 Oct 2017 05:10pm EDT 

Oct 26 (Reuters) - La Jolla Pharmaceutical Co :La Jolla Pharmaceutical Company announces financial results for the three and nine months ended September 30, 2017 and recent corporate progress.Q3 loss per share $1.19.Q3 earnings per share view $-1.24 -- Thomson Reuters I/B/E/S.La Jolla Pharmaceutical-‍as of Sept 30, 2017, co had $120.8 million in cash,cash equivalents, versus $65.7 million of cash and cash equivalents at Dec 31, 2016​.  Full Article

Prudential Financial reports 10.1 pct passive stake ​in La Jolla Pharmaceutical
Tuesday, 10 Oct 2017 12:35pm EDT 

Oct 10 (Reuters) - La Jolla Pharmaceutical Co ::Prudential Financial Inc reports 10.1 percent passive stake ​in La Jolla Pharmaceutical Co as of Sept 30 - sec filing ‍.  Full Article

FDA accepts La Jolla Pharmaceutical's NDA for LJPC-501
Monday, 28 Aug 2017 09:00am EDT 

Aug 28 (Reuters) - La Jolla Pharmaceutical Co :La Jolla Pharmaceutical Company announces U.S. Fda acceptance of new drug application for LJPC-501.La Jolla Pharmaceutical Co- ‍user fee goal date under prescription drug user fee act is February 28, 2018 for LJPC-501​.La Jolla Pharmaceutical-‍in letter to co, FDA stated it does not currently plan to hold advisory committee meeting to discuss application for LJPC-501​.  Full Article

La Jolla Pharma ‍announces launch of expanded access program for LJPC-501​
Tuesday, 8 Aug 2017 09:00am EDT 

Aug 8 (Reuters) - La Jolla Pharmaceutical Co ::La Jolla Pharmaceutical Co - ‍announces launch of expanded access program for LJPC-501​.  Full Article

La Jolla quarterly loss per share $1.21
Thursday, 27 Jul 2017 04:00pm EDT 

July 27 (Reuters) - La Jolla Pharmaceutical Co :La Jolla Pharmaceutical Company announces financial results for the three and six months ended June 30, 2017 and recent corporate progress.Quarterly loss per share $1.21.La Jolla Pharmaceutical Co - as of June 30, 2017, company had $141.3 million in cash and cash equivalents.  Full Article

La Jolla Pharmaceutical quarterly loss per share $1.26
Thursday, 27 Apr 2017 04:10pm EDT 

April 27 (Reuters) - La Jolla Pharmaceutical Co ::La Jolla Pharmaceutical Company announces financial results for the three months ended march 31, 2017 and recent corporate progress.Quarterly loss per share $1.26.Q1 earnings per share view $-1.34 -- Thomson Reuters I/B/E/S.  Full Article

La Jolla Pharmaceutical announces pricing of public offering of common stock
Thursday, 23 Mar 2017 08:00am EDT 

La Jolla Pharmaceutical Co : Says public offering of 3.70 million common shares priced at $33.50per share .La Jolla Pharmaceutical Company announces pricing of public offering of common stock.  Full Article

La Jolla Pharmaceutical Co announces proposed underwritten public offering of common stock
Monday, 20 Mar 2017 04:01pm EDT 

La Jolla Pharmaceutical Co : La Jolla Pharmaceutical Company announces proposed underwritten public offering of common stock . La Jolla Pharmaceutical Co - announced its intention to offer and sell $100 million of its common stock in an underwritten public offering .La Jolla Pharmaceutical Co - intends to use net proceeds from underwritten offering for future clinical trials of its drug candidates, among others.  Full Article

La Jolla Pharmaceutical files for mixed shelf of up to $150 million
Friday, 18 Nov 2016 05:46pm EST 

La Jolla Pharmaceutical Co :La Jolla Pharmaceutical Co - files for mixed shelf of up to $150 million - sec filing.  Full Article

BRIEF-La Jolla Pharma files for mixed shelf of up to $150 mln ‍​

* Files for mixed shelf of up to $150 million - SEC filing‍​ Source text : [http://bit.ly/2zK9cPg] Further company coverage: